Azilsartan

SKU: orb1309918

Description

Azilsartan (TAK-536) is a selective angiotensin II type 1 receptor antagonist used in research to study hypertension mechanisms. It is applied in both in vitro binding assays and in vivo models to investigate cardiovascular physiology and the renin-angiotensin system pathway.

Research Area

Cell Biology, Immunology & Inflammation, Metabolism Research, Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	147403-03-0
MW	456.45
Purity	99.87%
Formula	C₂₅H₂₀N₄O₅
SMILES	C(N1C=2C(N=C1OCC)=CC=CC2C(O)=O)C3=CC=C(C=C3)C4=C(C=CC=C4)C5=NOC(=O)N5
Target	Reactive Oxygen Species,RAAS,Apoptosis
Solubility	H2O:< 1 mg/mL (insoluble or slightly soluble);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.38 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble);DMSO:55 mg/mL (120.5 mM)

Bioactivity

−

Target IC50	AT1 receptor:2.6 nM
In Vivo	In Koletsky rats, Azilsartan treatment lowers blood pressure, basal plasma insulin concentration and the homeostasis model assessment of insulin resistance index, and inhibited over-increase of plasma glucose and insulin concentrations during oral glucose tolerance test. Azilsartan downregulates 11β-hydroxysteroid dehydrogenase type 1 expression. Read more...
In Vitro	Azilsartan inhibits the specific binding of 125I-Sar1-Ile8-AII to human angiotensin type 1 receptors. Azilsartan also inhibits the accumulation of AII-induced inositol 1-phosphate (IP1) in the cell-based assay with an IC50 value of 9.2 nM. In isolated rabbit aortic strips, Azilsartan reduces the maximal contractile response to AII with a pD'2 value of 9.9. The inhibitory effects of Azilsartan on contractile responses induced by AII persists after the strips are washed. Azilsartan suppresses the increase in plasma glucose level in the oral glucose tolerance test (OGTT) without significant change in insulin concentration and improved insulin sensitivity. In skeletal muscle, Azilsartan decreases the expression of TNF-α at doses of 0.001%. In adipose tissue, Azilsartan reduces TNF-α expression but increases the expression of adiponectin, PPARγ, C/EBα, and aP2. In cultured 3T3-L1 preadipocytes, Azilsartan enhances adipogenesis and exertes greater effects than valsartan on expression of genes encoding peroxisome proliferator-activated receptor-α (PPARα), PPARδ, leptin, adipsin, and adiponectin. Azilsartan also potently inhibits vascular cell proliferation in the absence of exogenously supplemented angiotensin II. Read more...
Cell Research	Twenty-four hours after transfections, the COS-7 cells expressing human AT1 receptors are starved by changing the culture medium to starvation buffer (1 mM CaCl2, 0.5 mM MgCl2, 4.2 mM KCl, 146 mM NaCl, 5.5 mM glucose, and 10 mM HEPES, pH 7.3). Then, 5 μL/well of Azilsartan dissolved in starvation buffer is added to the cells at the indicated concentrations, and they are pretreated for the indicated times. Two hours after starvation, LiCl is added to a final concentration of 50 mM with or without AII 10 nM, and the cells are further incubated for the indicated times at 37°C. In washout experiments, the cells are washed once with 100 μL/well of starvation buffer to remove unbound Azilsartan before stimulation with AII. The accumulation of inositol 1-phosphate (IP1) is measured by using an IP-One Tb kit. The fluorescence resonance energy transfer signal is measured on a plate reader.(Only for Reference) Read more...

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

KDR cells, inhibit, Ischemia, Neuroprotection, endothelial, Inhibitor, Hypertension, HepG2, adipogenesis, Angiotensin Receptor, Apoptosis, AT1 receptor, Azilsartan, cancer, Stroke, TAK 536, TAK536, TAK-536, Reactive Oxygen Species, vascular cell

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

135415867 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Azilsartan (orb1309918)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

CAS Number:	1824707-75-6
MW:	1016.081
Formula:	C₅₅H₅₃N₉O₁₁

CAS Number:	1346599-45-8
MW:	461.48
Formula:	C₂₅H₂₀N₄O₅

CAS Number:	2271428-31-8
MW:	676.71
Formula:	C₃₈H₃₆N₄O₈

CAS Number:	1596357-16-2
MW:	678.702
Formula:	C₃₆H₃₄N₆O₈

Purity:	98.72%
CAS Number:	863031-24-7
MW:	606.62
Formula:	C₃₀H₂₃N₄O₈·K

Azilsartan

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

Azilsartan trimethylethanolamine [orb1698219]

Azilsartan-d5 [orb1710344]

Azilsartan mopivabil [orb1739772]

Azilsartan mepixetil [orb1691596]

Azilsartan Medoxomil Potassium [orb2283881]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

Azilsartan (orb1309918)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors